Filtered By:
Vaccination: Cervical Cancer Vaccine
Countries: Canada Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 33 results found since Jan 2013.
The relationship of human papillomavirus positivity with tumor characteristics in an Irish penile cancer population
CONCLUSIONS: Our data is representative of the Irish landscape in penile cancer over the last five years. Using p16INK4a staining, we demonstrate a high rate of HPV prevalence in penile cancer cases in our patient cohort, which is associated with prognostically worse tumor subtypes. This would suggest that HPV vaccination of adolescent boys is a useful public health intervention in preventing penile cancer in the Irish male population.PMID:36656691 | PMC:PMC9851216 | DOI:10.5489/cuaj.7821
Source: Canadian Urological Association Journal - January 19, 2023 Category: Urology & Nephrology Authors: Eva Browne Megan Power Foley John O'Kelly Aisling Nic An R íogh Nigam Shah Christine Shilling John P Keane Padraig Daly Ivor M Cullen Source Type: research
School immunization coverage in adolescents during the COVID-19 pandemic: A retrospective cohort study
CONCLUSION: There was a substantial decrease in school-based immunization coverage during the COVID-19 pandemic, and coverage has not returned to pre-pandemic levels, suggesting further catch-up is needed.PMID:36642632 | PMC:PMC9826994 | DOI:10.1016/j.vaccine.2023.01.011
Source: Vaccine - January 15, 2023 Category: Allergy & Immunology Authors: Hannah Sell Yuba Raj Paudel Donald Voaklander Shannon E MacDonald Source Type: research
Factors influencing human papillomavirus school-based immunization in Alberta: A mixed-methods study protocol
This study has one overarching research question: what are parent/guardian and program stakeholder perceived barriers, enablers and opportunities to immunization for youth as part of the school-based HPV immunization program in Alberta? This study uses a mixed-methods sequential explanatory design. A survey will be emailed to a sample of Albertans with children aged 11-17 years. Questions will be based on a Conceptual Framework of Access to Health Care. Subsequent qualitative work will explore the survey's findings. Parents/guardians identifying as vaccine hesitant in the survey will be invited to participate in virtual, s...
Source: Cancer Control - December 1, 2022 Category: Cancer & Oncology Authors: Jennifer Malkin Lisa Allen Scott Amanda Alberga Machado Gary Teare Joanne Snider Syed Farhan Ali Tirmizi Thilina Bandara Mika Rathwell Cordell Neudorf Source Type: research
SOGC Guideline Retirement Notice No. 3
J Obstet Gynaecol Can. 2022 Nov;44(11):1226-1236. doi: 10.1016/j.jogc.2022.09.005.ABSTRACTThese documents have been archived because they contain outdated information. They should not be consulted for clinical use, but for historical research only. Please visit the journal website for the most recent guidelines. Prenatal Screening for Fetal Aneuploidy [J Obstet Gynaecol Can 29 (2007) 146-161] AUTHORS Anne Summers, MD, North York, ON Sylvie Langlois, MD, Vancouver, BC Phil Wyatt, MD, PhD, Toronto, ON R. Douglas Wilson, MD, Philadelphia, PA A Report on Best Practices for Returning Birth to Rural and Remote Aboriginal Communi...
Source: Rural Remote Health - November 21, 2022 Category: Rural Health Source Type: research
Increases in human papillomavirus vaccine coverage over 12 months among a community-recruited cohort of gay, bisexual, and other men who have sex with men in Canada
CONCLUSIONS: We observed substantial gains in HPV vaccine coverage among young GBM within 5 + years of targeted program implementation, but gaps remain, particularly among older men who are ineligible for publicly-funded programs. Findings suggest the need for expanded public funding or insurance coverage for HPV vaccines.PMID:35577633 | DOI:10.1016/j.vaccine.2022.05.019
Source: Vaccine - May 16, 2022 Category: Allergy & Immunology Authors: Catharine Chambers Shelley L Deeks Rinku Sutradhar Joseph Cox Alexandra de Pokomandy Troy Grennan Trevor A Hart Gilles Lambert David M Moore Fran çois Coutlée Daniel Grace Ramandip Grewal Jody Jollimore Nathan Lachowsky Rosane Nisenbaum Gina Ogilvie Cha Source Type: research
Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada
CONCLUSIONS: The publicly funded school-based qHPV vaccine program reduced AGW incidence in Manitoba by three-quarters in young females. AGW-related prescriptions are a poor proxy for medically attended AGW after the introduction of the publicly funded qHPV vaccination program. Different sexual habits in adolescents are, at most, responsible for a small portion of the reduction in AGW incidence.PMID:35472093 | DOI:10.1371/journal.pone.0267646
Source: Cancer Control - April 26, 2022 Category: Cancer & Oncology Authors: Christiaan H Righolt Karla Willows Erich V Kliewer Salaheddin M Mahmud Source Type: research
Covax, the Developing World ’ s Hope against COVID, Has Made It Only Halfway
Delivery of syringes for the vaccination campaign in El Salvador. Latin American countries have made steady progress in immunizing their populations, partly through direct negotiations between their governments and suppliers and partly through international cooperation. CREDIT: PAHO
By Humberto MárquezCARACAS, Jan 20 2022 (IPS) The Covax initiative, the hope of the countries of the developing South to immunize their populations against COVID-19, only met half of its goals in 2021. And as 2022 begins, and the omicron variant of the virus is spreading fast, the scheme still depends on the decisions of pharmaceutical compani...
Source: IPS Inter Press Service - Health - January 20, 2022 Category: International Medicine & Public Health Authors: Humberto Marquez Tags: COVID-19 Development & Aid Editors' Choice Featured Global Global Governance Headlines Health Humanitarian Emergencies Regional Categories TerraViva United Nations COVAX COVID-19 vaccines Source Type: news
High-risk HPV prevalence among women undergoing cervical cancer screening: Findings a decade after HPV vaccine implementation in British Columbia, Canada
CONCLUSIONS: This study illustrates the prevalence of hrHPV in BC over time in women undergoing cervical cancer screening, where an indication of a decline in HPV16/18 is seen in vaccine eligible women.PMID:34344555 | DOI:10.1016/j.vaccine.2021.07.009
Source: Vaccine - August 4, 2021 Category: Allergy & Immunology Authors: Charles Litwin Laurie Smith Robine Donken Mel Krajden Dirk van Niekerk Monika Naus Darrel Cook Arianne Albert Gina Ogilvie Source Type: research
